Impact of COVID-19 pandemic on bariatric surgery in India: An obesity and metabolic surgery society of India survey of 1307 patients

Background: Although safe practice guidelines were issued by the Obesity and Metabolic Surgery Society of India (OSSI) in the end of May 2020, surgeons have been in a dilemma about risk of subjecting patients to hospitalisation and bariatric surgery. This survey was conducted with the objective to e...

Full description

Saved in:
Bibliographic Details
Published in:Journal of minimal access surgery Vol. 17; no. 4; pp. 542 - 547
Main Authors: Bhasker, Aparna, Khaitan, Manish, Bindal, Vivek, Kumar, Amardeep, Rajkumar, Anirudh, Kaushal, Anshuman, Prasad, Arun, Parikh, Chirag, Sethi, Daksh, Goel, Deep, Hareendran, Deepak, Bedi, Digvijay, Jammu, Gurvinder, Leo, Jayanth, Kular, Kuldeepak, Narwaria, Mahendra, Chikkachanappa, Mahesh, Motwani, Manish, Bharucha, Manoj, Ismail, Mohamed, Dukkipati, Nandkishore, Shah, Neha, Tantia, Om, Patel, Parag, Padmakumar, R, Singh, Rahul, Palaniappan, Raj, Shrivastava, Rajesh, Pal Rajput, Ram, Goel, Ramen, Wadhawan, Randeep, Garg, Rohit, Aggarwal, Sandeep, Patolia, Sanjay, Baig, Sarfaraz, Shah, Shashank, Shivaram, H, Dhorepatil, Shrihari, Saggu, Sukhvinder, Ugale, Surendra, Perungo, T, Soni, Vandana
Format: Journal Article
Language:English
Published: India Wolters Kluwer India Pvt. Ltd 01-10-2021
Medknow Publications and Media Pvt. Ltd
Medknow Publications & Media Pvt. Ltd
Wolters Kluwer - Medknow
Wolters Kluwer Medknow Publications
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background: Although safe practice guidelines were issued by the Obesity and Metabolic Surgery Society of India (OSSI) in the end of May 2020, surgeons have been in a dilemma about risk of subjecting patients to hospitalisation and bariatric surgery. This survey was conducted with the objective to evaluate the risk of coronavirus disease-19 (COVID-19) infection in peri- and post-operative period after bariatric and metabolic surgery (BMS). Methods: A survey with OSSI members was conducted from 20 July 2020 to 31 August 2020 in accordance with EQUATOR guidelines. Google Form was circulated to all surgeon members through E-mail and WhatsAppTM. In the second phase, clinical details were captured from surgeons who reported positive cases. Results: One thousand three hundred and seven BMS were reported from 1 January 2020 to 15 July 2020. Seventy-eight per cent were performed prior to 31 March 2020 and 276 were performed after 1 April 2020. Of these, 13 (0.99%) patients were reported positive for COVID-19 in the post-operative period. All suffered from a mild disease and there was no mortality. Eighty-seven positive cases were reported from patients who underwent BMS prior to 31 December 2019. Of these, 82.7% of patients had mild disease, 13.7% of patients had moderate symptoms and four patients succumbed to COVID-19. Conclusion: BMS may be considered as a safe treatment option for patients suffering from clinically severe obesity during the COVID-19 pandemic. Due care must be taken to protect patients and healthcare workers and all procedures must be conducted in line with the safe practice guidelines.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0972-9941
1998-3921
DOI:10.4103/jmas.JMAS_2_21